baber/WOPTO huggingface dataset:
Patent NZ-544486-A (NZ)
Title: Aglycosyl anti-cd154 (cd40 ligand) antibodies and uses thereof
Inventor: TAYLOR FREDERICK R
IPC: C07K16/28
Filed: 2004-06-14
Abstract: Disclosed are aglycosyl anti-CD154 antibodies or antibody derivatives, characterized by a modification at the conserved N-linked site in the CH2 domains of the Fc portion of said antibody. It also relates to the treatment of immune response related diseases and inhibition of unwanted immune response with such aglycosylated anti-CD154 antibodies or antibody derivatives thereof.
Patent NZ-546988-A (NZ)
Title: Decorative fencing system with post received in sleeve of stake and gate or fence ring(s) slid over post
Inventor: LANGENWALTER DUANE
IPC: E04H17/16
Filed: 2005-03-10
Abstract: A decorative fencing system is provided for use as a small fence or decorative accent for a yard. The fencing system comprises several different structural components that may be joined in various combinations so as to create a limitless number of different configurations or arrangements. The components include base units, decorative end units and gate units, each of which may be attached to the other components in any combination thereof. Each of these components are attached to post sections which are inserted through post rings or post hinges on the individual components to thereby allow for each component to be rotated to the desired position relative to the post section.; The post sections are secured to the ground by means of stakes that are first driven into the ground and the post section is then inserted into a sleeve in the stake to thereby provide support and stability for the fencing system. A separate and smaller pin is provided on the end units to anchor these components to the ground.
Patent NZ-549871-A (NZ)
Title: Substantial point of light alignment within a reflector
Inventor: MAGLICA ANTHONY
IPC: F21V15/01
Filed: 2005-03-08
Abstract: A flashlight is provided with an arrangement whereby the source of light 3 may be aligned with respect to an axis 43 of a reflector. The reflector 82 has a first open end 83 for emitting a light beam, a second end 85 and an axis 43 extending between the first and second reflector ends. The light source 3 is secured to the movable holder 90 and is disposed about the second end of the reflector. An actuating member is operatively coupled to the movable holder at an actuation interface 58 for moving the light source axially relative to the axis of the reflector and axially aligning the light source with the reflector axis and the focal point of the reflector. The movable light source holder includes a first electrode contact 28 extending from the light source to the base of the light source holder and a second electrode contact 29 extending from the light source to the side of the light source holder, the respective contacts for contacting the electrical contacts from the batteries of the flashlight.
Patent NZ-554031-A (NZ)
Title: Osteogenic oligonucleotides and uses thereof
Inventor: LOPEZ RICARDO AGUSTIN
IPC: A61K31/7125
Filed: 2005-09-12
Abstract: Disclosed is the use of an oligonucleotide having 14 to 100 nucleotides for the manufacture of a medicament for the treatment of a deficiency in bone to restore bone integrity characterised in that said oligonucleotide has at least one subsequence with the following composition: PyNTTTTNT or PyNTTTTGT, wherein Py is C or T and wherein N is any deoxyribonucleotide.
Patent NZ-555987-A (NZ)
Title: Simple gas scouring method and apparatus
Inventor: MULLER JOACHIM
IPC: B01D65/02
Filed: 2005-12-22
Abstract: A method of cleaning a membrane (6) in a membrane filtration system is disclosed by flowing gas bubbles past the surfaces of the membrane (6) to scour accumulated solids therefrom. The method includes flowing a liquid past a supply of gas; creating a reduced pressure within the liquid flow to cause a flow of gas from the supply of gas (9) into the liquid flow and form gas bubbles therein and then flowing the liquid containing the gas bubbles past the surfaces of the membrane (6) to scour the surfaces thereof. Apparatus for performing the method is also disclosed.
Patent NZ-563281-A (NZ)
Title: Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases
Inventor: ZELDIS JEROME B
IPC: A61K31/4035
Filed: 2003-05-16
Abstract: Disclosed herein is a use of 4-(amino)-2-(2,6-dioxo(3-piperidyl))-isoindoline-1,3-dione, or a pharmaceutically acceptable salt, solvate or stereoisomer thereof, for the manufacture of a pharmaceutical composition for the treatment of a ovarian cancer, pancreatic cancer and colorectal cancer.
Patent NZ-563345-A (NZ)
Title: Stopper device for the neck of a container provided with such a device method for stopping such a container and method for production of such a device
Inventor: LUZZATO MICHEL
IPC: B65D41/04
Filed: 2006-05-12
Abstract: The invention relates to a stopper device (1) for decreased contamination and improved appearance, comprising an external cap (10) made from plastic and an internal fixed fixing insert (20) for fixing the device around the neck of the container (2). The sleeve (12) of the cap successively comprises, along the (X-X) axis thereof, a head (13), into which the insert may be introduced and permanently fixed and a skirt (14) extending axially from the insert. At the base of the neck, the skirt essentially forms a frustum (142) converging towards the axis of the sleeve on extending from the head, before the installation of the device around the neck. The frustum forms, at the end (144) thereof opposite the head, an internal surface (144B) to come into contact against the container neck under the influence of an elastic deformation of the sleeve as a result of the installation of the device around the neck.
Patent NZ-569867-A (NZ)
Title: Novel 11 Beta-hydroxyandrosta-4-ene-3-ones
Inventor: PATEL JITEN RANCHHODBHAI
IPC: C07J3/00
Filed: 2007-01-29
Abstract: Disclosed is an 11-beta-hydroxyandrosta-4-ene-3-one, or a physiologically acceptable salt thereof wherein Z represents O or S; R1 represents hydrogen or methyl; R2 and R3 are the same or different and each independently represents hydrogen or halogen; R5 represents a group selected from alkyl, cycloalkyl, -O-alkyl, aryl or heterocyclic ring and R4 and R6 are defined in the specification.
Patent NZ-574208-A (NZ)
Title: Improved method and system for transacting commodities
Inventor: TOMLINSON DAVID WILLIAM GEORGE
IPC: G06Q30/08
Filed: 2007-06-19
Abstract: A method of conducting an electronic transaction for commodities in return for consideration and an electronic transaction system are disclosed. The system comprises transactor accounts for holding one or more of considerations, transaction funds, and commodities; communication access for transactors to participate in a transaction process and manage their accounts; a funds verifier configured to verify that a prospective purchaser in a transaction has sufficient consideration in one of the transactor accounts to match a purchase offer or to complete the transaction the consideration being held within an account of said prospective purchaser; and a locking device configured to lock against further use of the consideration so that the consideration remains available to complete the transaction while a valid transaction is in place
Patent NZ-575038-A (NZ)
Title: A facility for effluent separation having an open reservoir partitioned into two effluent receiving zones by weeping walls and a liquid outake located between the weeping walls
Inventor: LEWIS LINDSAY RONALD
IPC: A01K1/01
Filed: 2007-09-26
Abstract: A facility for, in or adjacent a dairy milking and/or a feeding facility adapted for separating effluent solids from effluent liquid, is disclosed. The facility has an open reservoir, and is partitioned into two effluent receiving zones where each zone is able to receive effluent from the milking and/or feeding facility. A liquid outtake zone is located within the reservoir and is accessible to effluent liquid from each of the effluent receiving zones via a pair of at least substantially parallel weeping walls dedicated to the specific effluent receiving zone. The weeping walls restrict movement of solids not able to weep through either weeping wall to the liquid outtake. (62) Divided Out of 573232
Patent NZ-576906-A (NZ)
Title: Continuous self-cleaning centrifuge assembly
Inventor: CHAN CHRIS KWOK ON
IPC: B04B1/00
Filed: 2007-11-15
Abstract: Provided is a continuous self-cleaning centrifuge assembly, having a feed inlet to the centrifuge for unclarified liquid and an outlet for clarified liquid, further including means to discharge solids out of a solids holding space in the centrifuge in response to a monitored turbidity parameter of liquid in a detection line, where in the detection line is in communication with the centrifuge separately from said outlet such that said turbidity parameter is affected by the degree of build up of solids in the centrifuge.
Patent NZ-579115-A (NZ)
Title: A chemical product providing system and method for providing a chemical product
Inventor: METZ THOMAS
IPC: C01B3/06
Filed: 2009-08-18
Abstract: Disclosed is a chemical product providing system, comprising an electrolyser and a gasification unit, whereas the gasification unit is provided to be fed with oxygen, resulted from the electrolyser, and to produce a synthesis gas, the synthesis gas being a source material for the chemical product, wherein the synthesis gas is provided to be fed to a water gas shift reactor, in which carbon monoxide is provided to react with water in a chemical reaction to form carbon dioxide and hydrogen and the hydrogen produced by the water gas shift reactor and stored hydrogen produced by the electrolyser and the synthesis gas is provided to selectively be fed: (a) to a carbon to hydrogen ratio adjustment unit adapted to change the ratio of carbon and hydrogen within the synthesis gas, leading to a modified synthesis gas with modified carbon and hydrogen ratio and/or (b) to the product synthesis unit adapted to create the chemical product.
Patent NZ-583103-A (NZ)
Title: Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors
Inventor: ARMANI ELISABETTA
IPC: A61K31/44
Filed: 2008-07-17
Abstract: Disclosed are compounds of formula (I) and acceptable salts and N-oxides thereof and its method of synthesis. Specific examples of compounds of formula (I) are: (S)-2-(4-isobutyl-phenyl)-propionic acid 2-(3,5-dichloropyridin-4-yl)-1-{ 3,4-dimethoxy-phenyl)ethyl ester, (S)-2-(4-isobutyl-phenyl)-propionic acid 2-(3,5-dichloro-1-oxy-pyridin-4-yl)-1-(3,4-dimethoxy-phenyl)ethyl ester, and 2-oxo-thiazolidine-4-carboxylic acid 1-(3-cyclopropylmethoxy-4-difluoromethoxy-phenyl)-2-(3,5-dichloro-1-oxy-pyridin-4-yl)ethyl ester. Also disclosed is the use of compounds of formula (I) for the treatment of any disease characterized by phosphodiesterase 4 (PDE4) overactivity including respiratory tract diseases like airway obstruction, asthma, chronic bronchitis or chronic obstructive pulmonary disease.
Patent NZ-586181-A (NZ)
Title: Load suspension device that can be adjusted, locked, and braced horizontally, by means of hydraulics
Inventor: MULLER CONRAD
IPC: B66C1/66
Filed: 2010-06-15
Abstract: A load suspension device is disclosed that can be adjusted, locked and braced horizontally by means of hydraulics is disclosed. The device is typically used wherever spreaders are used, and more typically for freight containers of differing lengths. Distance sensors are used to activate blocking of flow of hydraulic fluid to lock the device.
Patent NZ-594396-A (NZ)
Title: Seed drill with digging tines preceding seeding tines and being aligned so that soil is only disturbed in parallel spaced apart linear regions
Inventor: CLAYDON JEFFREY THOMAS
IPC: A01B49/06
Filed: 2007-08-03
Abstract: An apparatus is provided for cultivating soil and sowing seed. The apparatus comprises (a) a frame means adapted in use to be towed by, or attached to the rear of, a tractor, (b) a first row of spaced apart digging tines carried by the frame means, (c) a first row of seeding tines carried by the frame means, each of the seeding tines being aligned with a respective one of the digging tines to the rear of and spaced from the first row of digging tines measured in a direction parallel to the direction of forward motion of the apparatus when in use, (d) a second row of spaced apart digging tines carried by the frame means, none of which are aligned with any of the tines in the first row of digging tines, (e) a second row of seeding tines carried by the frame means, each of which is aligned with a respective one of the tines in the second row of digging tines. In use, soil will only be disturbed in parallel spaced apart linear regions where the spacing is determined by the lateral spacing between the tines in the two rows of digging tines, and leaving uncultivated strips of soil therebetween.
Patent NZ-596007-A (NZ)
Title: A method of calibrating inertial sensors
Inventor: DUSHA DAMIEN
IPC: G01C25/00
Filed: 2010-10-21
Abstract: Disclosed is a method of calibrating inertial sensors (2) of working equipment. Data is captured from one or more inertial sensors (2) and one or more temperature sensors located proximate the inertial sensors (2) while the working equipment is not in operation. A thermal bias error model is updated for the inertial sensors (2) with the data captured from the inertial sensors (2) and the temperature sensors.
Patent NZ-596628-A (NZ)
Title: Ketolide compounds having antimicrobial activity
Inventor: TRIVEDI BHARAT KALIDAS
IPC: A61P31/04
Filed: 2010-05-26
Abstract: The invention relates to ketolide compound of Formula (I) and the pharmaceutically acceptable salts thereof having antimicrobial activity. The invention also provides pharmaceutical compositions containing the compounds of invention and methods of treating or preventing microbial infections with the compound of invention.
Patent NZ-596666-A (NZ)
Title: Tamper-resistant dosage form for oxidation-sensitive opioids
Inventor: GRIESSMANN KORNELIA
IPC: A61K9/20
Filed: 2010-07-21
Abstract: 596666 Disclosed herein is a thermoformed pharmaceutical dosage form having a breaking strength of at least 300 N, said dosage form comprising an opioid (A), a free physiologically acceptable acid (B) in an amount of from 0.001 to 5.0 wt.-%, based on the total weight of the pharmaceutical dosage form, and a polyalkylene oxide (C) having a weight average molecular weight Mw of at least 200,000 g/mol.
Patent NZ-599162-A (NZ)
Title: Compounds having Phosphoinositide 3-kinase Inhibitor Activity
Inventor: HARDY GEORGE
IPC: A61K31/519
Filed: 2010-10-19
Abstract: 599162 Disclosed herein is a compound of formula (I), wherein the variables are defined in the specification, and the use thereof in the treatment of COPD, asthma, paediatric asthma, cystic fibrosis, sarcoidosis, idiopathic pulmonary fibrosis, allergic rhinitis, rhinitis, sinusitis, allergic conjunctivitis, conjunctivitis, allergic dermatitis, contact dermatitis, psoriasis, ulcerative colitis, inflamed joints secondary to rheumatoid arthritis or osteoarthritis, rheumatoid arthritis, pancreatitis, cachexia, inhibition of the growth and metastasis of tumours including non-small cell lung carcinoma, breast carcinoma, gastric carcinoma, colorectal carcinomas and malignant melanoma. Specific embodiments of the compound include: 2-((4-amino-3-(3-hydroxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)methyl)-3-(2-chlorobenzyl)-5-ethynylquinazolin-4(3H)-one, 6-(2-((4-amino-3-(4-hydroxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)methyl)-3-(2-chlorobenzyl)-4-oxo-3,4-dihydroquinazolin-5-yl)hex-5-ynoic acid, 3-((2-((4-amino-3-(3-hydroxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)methyl)-5-ethynyl-4-oxoquinazolin-3(4H)-yl)methyl)benzonitrile, and 6-(2-((4-Amino-3-(4-hydroxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)methyl)-3-(2-chlorobenzyl)-4-oxo-3,4-dihydroquinazolin-5-yl)-N-methyl-N-(2-(4-methylpiperazin-1-yl)ethyl)hex-5-ynamide.
Patent NZ-602283-A (NZ)
Title: A device to enhance the traction of a tracked vehicle
Inventor: BURLING JOHN MENZIES
IPC: B62D55/28
Filed: 2011-02-08
Abstract: A device (1) for use with a continuous track (3) of a tracked vehicle to enhance the traction of the vehicle is disclosed. The device (1) has an elongate body (5) having a ground contacting surface (6) and a releasable bracket (7) for releasably securing the elongate body (5) to the continuous track (3). The releasable bracket (7) has a bracket body, a first clamping member (13), a second clamping member extending at an angle relative to the first clamping member, and a fastener. The bracket is arranged such that fastening the fastener causes the second clamping member to draw the first clamping member (13) towards the elongate body (5) to releasably secure the elongate body (5) to the continuous track (3). The device has one or more ground engaging features. A kit of parts is also described.
Patent NZ-603162-A (NZ)
Title: Capsule pharmaceutical dosage form comprising a suspension formulation of an indolinone derivative
Inventor: MESSERSCHMID ROMAN
IPC: A61K9/10
Filed: 2009-06-04
Abstract: Disclosed is a viscous lipid suspension formulation of 3-Z-[1-(4-(N-((4-methyl-piperazin-1-yl)-methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone-monoethanesulphonate comprising a lipid carrier (such as acetylated monoglycerides, corn oil glycerides, ethyl oleate, glycerol mono/dioleate, glycerol monolinolate, macrogolglycerol caprylocaprate, macrogolglycerol linoleate, medium chain partial glycerides, medium chain triglycerides, caprylic-capric triglycerides, caprylic/capric/linoleic triglycerides, caprylic/capric/succinic triglycerides, propylene glycol dicaprylate/dicaprate, oleic acid, polyoxyl castor oil, polyoxyl hydrogenated castor oil, propylene glycol monocaprylate, propylene glycol monolaurate, refined animal derived oil, refined soybean oil, refined vegetable oil, sorbitan monostearate, or mixtures thereof), a thickener (such as semisolid highly viscous or solid polyethyleneglycols, oleogel forming excipients, lipophilic or amphiphilic excipients of high viscosity, and hard fats) and a glidant/solubilizing agent (i.e. lecithin). Also disclosed is a capsule comprising a capsule shell (such as a soft gelatine capsule, a hard gelatine, a hydroxypropylmethylcellulose (HPMC) capsule, a polyvinyl alcohol polymer capsule or a pullulan capsule) and a capsule formulation, wherein the capsule formulation comprises the formulation as defined above, and wherein the viscosity of the liquid system is a crucial parameter to ensure adequate drug release.
Patent NZ-603469-A (NZ)
Title: Feeder mechanism retention device for fastener driving tool
Inventor: MOELLER LARRY M
IPC: B25C1/00
Filed: 2012-11-07
Abstract: 603469 A fastener driving tool employing magazines feeding fasteners to a nosepiece for receiving a driving force. The tool has a power source including a reciprocating drive piston and associated driver blade disposed within a cylinder (20). A tool nose is associated with the power source for receiving the driver blade for driving fasteners (26) fed into the nose. The tool includes a magazine constructed and arranged to house a supply of the fasteners (26). A magazine feeder mechanism (50) is associated with the magazine for sequentially feeding fasteners (26) into the nose, the feeder mechanism (50) including a feed piston (58) reciprocating between an advanced position and a retracted position relative to the tool nose. A gas conduit (44) is in fluid communication with power source gases and a feed cylinder (56) housing the feed piston (58). An electromechanical retention device (110) retains the feed piston (58) in the retracted position until the driver blade reaches a pre-firing position, the electromechanical retention device (110) being an electromagnet (112) disposed to operationally engage the feed piston (58). A control module in the tool controls the electromagnet (112) for determining an energisation cycle of the electromagnet (112) for retaining the feed piston (58) in the retracted position until the driver blade reaches the pre-firing position for preventing side loading against the driver blade by a next fastener (26) to be driven.
Patent NZ-621710-A (NZ)
Title: Formulations and dosage forms of oxidized phospholipids
Inventor: SHER NAAMIT
IPC: A61P29/00
Filed: 2012-08-31
Abstract: The current disclosure provides pharmaceutical compositions containing an oxidized phospholipid, such as 1-hexadecyl-2-(4’-carboxybutyl)-glycero-3-phosphocholine (VB-201) and a thermosoftening carrier, e.g. a poloxamer. The pharmaceutical compositions may further comprise an anti-adherent agent, such as talc and/or a thixotropic agent. The current disclosure further provides processes for preparing the pharmaceutical compositions. The disclosure further provides capsules containing the pharmaceutical compositions. Uses of such pharmaceutical compositions and capsules in treating inflammatory disorders are also disclosed.
Patent NZ-626100-A (NZ)
Title: Diagnostic test for bacterial pathogens using internal control bacterial strain
Inventor: BARKER COLIN RICHARD
IPC: C12Q1/68
Filed: 2012-12-21
Abstract: Discloses a method for detecting the presence or absence of Streptococcus equi in a biological sample, the method comprising the steps of: (a) adding a control bacterial strain to a biological sample obtained from a human or animal subject, wherein the genome of the control bacterial strain contains a target sequence region which differs from a sequence within Streptococcus equi; (b) assessing the sample for the presence or absence of one or more genes specific for Streptococcus equi, wherein positive identification of the one or more genes specific for Streptococcus equi is indicative of a positive identification for Streptococcus equi in the biological sample; and (c) assessing the sample for the presence of the target sequence region within the control bacterial strain, wherein positive identification of the target sequence region within the control bacteria is indicative of an accurate result for step (b).
Patent NZ-703824-A (NZ)
Title: Oligonucleotides for making a change in the sequence of a target rna molecule present in a living cell
Inventor: DE BOER DANIEL ANTON
IPC: C12N15/11
Filed: 2013-07-12
Abstract: The present invention relates to a single-stranded oligonucleotide, wherein all nucleosides of the oligonucleotide are 2’ O alkyl ribose ribonucleosides, for use in the treatment of the human or animal body, wherein said oligonucleotide is capable of making a change in the sequence of a target RNA molecule present in a living cell of said human or animal body, by providing the oligonucleotide to the living cell under conditions allowing uptake by the living cell of said oligonucleotide, wherein said oligonucleotide comprises a sequence that is at least partially complementary to the target RNA molecule, such that hybridization of the oligonucleotide to the target RNA, or a precursor thereof, or a template therefor, takes place in said living cell, allowing biochemical machinery present in said living cell to copy a difference in sequence of the oligonucleotide relative to the target RNA molecule onto the RNA molecule, either directly or via a precursor thereof or a template there for, so as to bring about the change in said target RNA.
Patent NZ-712713-A (NZ)
Title: Attenuated swine influenza vaccines and methods of making and use thereof
Inventor: HAUSE BENJAMIN M
IPC: C12N7/00
Filed: 2013-07-11
Abstract: An attenuated swine influenza strain capable of providing a safe and effective immune response in a porcine animal against a virulent H3N2 swine influenza or diseases caused by H3N2 swine influenza. The attenuated strain encodes an HA protein comprising (i) four additional glycosylation sites, relative to its corresponding virulent parental strain; and (ii) having at least 90% identity to a sequence as set forth in SEQ ID NO: 24, provided that the following locations have the following amino acids: 71N, 90N, 173T, 287T and wherein amino acid 294 is not 294T. The virulent parental strain is an H1N1 swine influenza strain encoding an HA protein having the sequence as set forth in SEQ ID NO:18.